New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
24 Oct 11:30 · WIRED
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
24 Oct 11:30 · WIRED
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
24 Oct 11:30 · WIRED
Melanoma vaccine reduces death or cancer recurrence by 42%
In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each patient's own tumor, to pembrolizumab immunotherapy after surgery for high-risk ...
23 Oct 22:00 · Medical Xpress
A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
22 Oct 23:54 · TIME
Personalised mRNA Cancer Vaccine Cuts Melanoma Recurrence
Moderna and Merck report that their personalised mRNA cancer vaccine combined with Keytruda cuts melanoma recurrence or death risk by 42%.
22 Oct 22:28 · Greek City Times
last updated on 24 Oct 12:39